Skip to main content
M&M 2023 Meeting (Microscopy & Microanalysis) Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Song Pang

Research Director, FIB-SEM Collaboration Core
Yale School of Medicine
New Haven, Connecticut, United States

Song Pang's primary research focus is to nucleate transformative technology development and foster discoveries in life science. As the Director of FIB-SEM Collaboration Core at Yale School of Medicine (YSM), she aims to expand the application space of the enhanced FIB-SEM technology beyond experimental model systems to the realms of translational and clinical research. Pang envisions her organization to be a discovery powerhouse, consisting of a cutting-edge imaging pipeline from x-ray guided FIB-SEM sample preparation, large volume 3D high-resolution imaging, to data registration and segmentation.

Prior to joining YSM, Pang was the lead scientist in the FIB-SEM Technologies group at the Janelia Research Campus of Howard Hughes Medical Institute, where she led the development of the tissue pipeline for the applications of enhanced FIB-SEM technology. Together with her colleagues, she also created the first open-access 3D atlas at the finest isotropic resolution using the enhanced FIB-SEM platform. In addition, she brought her expertise of semiconductor device integration into brain research and directed every aspect of device fabrication of customized extra cellular neuroprobes during path-finding phase, initiating the Neuroprobe project with IMEC that turned into a multi-institute collaboration.

Since 2020, the proprietary enhanced FIB-SEM technology and its unparalleled pipeline have enabled numerous transformational discoveries, many of which were major new landmarks in their fields. At the forefront of volume electron microscopy, Pang is committed to cultivating a healthy ecosystem among imaging technology, a wide range of applications, and data pipeline, synergistically elevating the research in life science to a whole new level. She welcomes collaborations and looks forward to exploring new partnerships.

Disclosure information not submitted.

Presentation(s):